| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/2006 | US20060154917 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154915 Substituted biaryl compounds as factor XIa inhibitors |
| 07/13/2006 | US20060154914 Dibenzoxazepinone derivatives and uses thereof |
| 07/13/2006 | US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation |
| 07/13/2006 | US20060154912 Isophtalic acid derivatives |
| 07/13/2006 | US20060154911 Apoptosis-inducing antineoplastic silver (I) coordination complexes |
| 07/13/2006 | US20060154910 Use of steroids to treat ocular disorders |
| 07/13/2006 | US20060154909 1,4,6-androstatriene-3,17-dione ("ATD") for therapeutic uses |
| 07/13/2006 | US20060154908 Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154906 Methods and related compositions for the non-surgical removal of fat |
| 07/13/2006 | US20060154905 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/13/2006 | US20060154904 Betulinol derivatives as anti-HIV agents |
| 07/13/2006 | US20060154903 Betulinol derivatives as anti-cancer agents |
| 07/13/2006 | US20060154902 Shortening of hospital stay and improving survival in patients with chronic kidney disease |
| 07/13/2006 | US20060154901 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 07/13/2006 | US20060154900 Diphosphonate solutions |
| 07/13/2006 | US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 07/13/2006 | US20060154898 Diphosphonate solutions |
| 07/13/2006 | US20060154897 Ophthalmic compositions for treating ocular hypertension |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154895 Method of treating acquired immunedeficiency syndrome |
| 07/13/2006 | US20060154894 Biologically active surfaces and methods of their use |
| 07/13/2006 | US20060154893 Exopolysaccharides delivery system for active molecules |
| 07/13/2006 | US20060154892 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 07/13/2006 | US20060154891 Ready-to-use gemcitabine solutions and gemcitabin concentrates |
| 07/13/2006 | US20060154890 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 07/13/2006 | US20060154881 9A,11-2C-bicyclic 9a-azalide derivatives |
| 07/13/2006 | US20060154880 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 07/13/2006 | US20060154879 Avermectins substituted in the 4" and 4'-positions having pesticidal properties |
| 07/13/2006 | US20060154878 for treating bacterial infections; intermediates for the synthesis of other macrolide antibiotics |
| 07/13/2006 | US20060154877 Aglycone of 2-methylene-butane-1,3,4-triol acylated by caffeic acid, e.g., 4-caffeoyloxy-2-hydroxy-3-methylenebutane-1-O- beta -D-glucopyranoside and 2-caffeoyloxy-4-hydroxy-3-methylenebutane-1-O- beta -D-glucopyranoside |
| 07/13/2006 | US20060154876 Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 07/13/2006 | US20060154875 Thienoisoquinoline-phenylsulfonamides and their use as ER-NFkappaB inhibitors |
| 07/13/2006 | US20060154874 Treatment of symptoms associated with bacterial vaginosis |
| 07/13/2006 | US20060154873 Aseptic combination preparation |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | US20060154867 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 07/13/2006 | US20060154857 G1 phase arresting compound is rapamycin and the HIV antiviral agent is T20 (enfuvirtide); enhances the activity of the antiviral agent |
| 07/13/2006 | US20060154856 NADPH oxidase inhibition pharmacotherapies for Obstructive Sleep Apnea syndrome and its associated morbidities |
| 07/13/2006 | US20060154312 Tubulin isotype screening in cancer therapy using halichondrin B analogs |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060153941 Pharmaceutical compositions comprising cabbinochreme type compounds |
| 07/13/2006 | US20060153940 Use of physiologically active fatty acids |
| 07/13/2006 | US20060153939 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
| 07/13/2006 | US20060153937 Synergistic composition for the treatment of diabetes mellitus |
| 07/13/2006 | US20060153935 Stabilizing salicylate compositions and method of preparation for oral and topical use |
| 07/13/2006 | US20060153934 Oxide; increased prostacyclin activity; oral formulations; diabetes, diabetic complications, dyslipidemia, and metabolic disorders |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | US20060153930 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 07/13/2006 | US20060153927 Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ |
| 07/13/2006 | US20060153926 Compositions, products and methods for controlling weight in a mammal |
| 07/13/2006 | US20060153925 Novel solid pharmaceutical composition comprising amisulpride |
| 07/13/2006 | US20060153917 Enteric coated bead comprising ixabepilone, and preparation and administration thereof |
| 07/13/2006 | US20060153916 Novel dosage form |
| 07/13/2006 | US20060153915 Sustained-release preparations and method for producing the same |
| 07/13/2006 | US20060153914 Treating or preventing myocardial ischemia and angina pectoris; time-release Galenical preparation |
| 07/13/2006 | US20060153913 Solid formulation with improved solubility and stability, and method for producing said formulation |
| 07/13/2006 | US20060153912 Choline ascorbate formulations |
| 07/13/2006 | US20060153910 Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins |
| 07/13/2006 | US20060153909 Hard capsule |
| 07/13/2006 | US20060153908 Spherical pellet formulations |
| 07/13/2006 | US20060153907 Liposome formulations of boronic acid compounds |
| 07/13/2006 | US20060153906 Pharmaceutical product for endonasal administration for treating central nervous system disease and disorders |
| 07/13/2006 | US20060153900 Dietary supplement for treatment of lipid risk factors |
| 07/13/2006 | US20060153896 Methods and devices for improving biofixation of implantable vascular devices |
| 07/13/2006 | US20060153895 Drug-containing implants and methods of use thereof |
| 07/13/2006 | US20060153893 Therapeutic composition for bone infectious disease |
| 07/13/2006 | US20060153882 Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound |
| 07/13/2006 | US20060153867 To modulate the activity of one or more protein kinase C isozymes |
| 07/13/2006 | US20060153859 Ganglioside-KLH conjugate vaccine with QS-21 |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153844 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| 07/13/2006 | US20060153842 Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection |
| 07/13/2006 | US20060153839 Production of bispecific molecules using polyethylene glycol linkers |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153832 Immunomodulating polymers |
| 07/13/2006 | US20060153829 Stable formulations of purified proteins |
| 07/13/2006 | US20060153828 Plasmid-specific polypeptide found in Eschericha; splitting esterase inhibitor; antibodies |
| 07/13/2006 | US20060153824 Methods and kits for co-administration of nutritional supplements |
| 07/13/2006 | US20060153823 Compositions and methods for nutritional supplementation |
| 07/13/2006 | US20060153806 Proteins involved in the regulation of energy homeostasis |
| 07/13/2006 | US20060153803 administering a combination of genetic engineered interferon and ribavirin to in vitro cells capable of being infected with RNA viruses; prevention of severe acute respiratory syndrome (SARS) |
| 07/13/2006 | US20060153797 Tissue material and matrix |
| 07/13/2006 | US20060153796 Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant |
| 07/13/2006 | US20060153795 Macromer having at least one NO carrying region or NO modulating compound which is released from the macromer; restenosis, thrombosis, asthma, wound healing, arthritis, penile erectile dysfunction |
| 07/13/2006 | US20060153794 Hair tonics and method of screening the same |
| 07/13/2006 | US20060153786 biodegradable drug delivery system; fungal infection; inflammation; injection |
| 07/13/2006 | US20060153782 Skin photoageing and actinic damage treatment |
| 07/13/2006 | US20060153781 Repair of dna mutagenic damage |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060153778 Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| 07/13/2006 | US20060153777 Aerosol formulation for inhalation containing an anticholinergic |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060151574 Formulations useful against hepatitis C virus infections |
| 07/13/2006 | DE19713768B4 Herstellung von Betulinsäure Production of betulinic |
| 07/13/2006 | DE102005028077A1 Alkinyl-substituierte Thiophene Alkynyl-substituted thiophenes |
| 07/13/2006 | DE102005000746A1 Bekämpfung der Histomoniasis Controlling histomoniasis |
| 07/13/2006 | DE102004063797A1 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide Oxygen-containing fused phenylpiperazine and Phenyldiazepancarboxamide |